Drug safety in the limelight
Article
Pharmaceutical Technology Europe
Pharmaceutical Technology EuropePharmaceutical Technology Europe-05-01-2003
Volume 15
Issue 5
Regular update from Washington.
The US Food and Drug Administration (FDA) is proposing that barcodes be used on drug packages, and that new error reporting standards should be introduced as part of the campaign to reduce medication errors.
This article is currently available in printed form only.
To ensure access to all articles from every issue of Pharmaceutical Technology Europesubscribe here now.
Articles in this issue
The New Tabletting Facility
Nobler in the Mind? The Dilemma for European Research
European Union Local Language Requirements and How Labelling Systems May Provide a Solution
The Death of the Drug Dossier
Drug safety in the limelight
Qualification of a Chromotographic Column
21 CFR Part 11: The New Draft Guidance
Recent Videos
Related Content
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Article
Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.
